1,200 articles
Omid Hamid
Omid Hamid is an American medical oncologist and melanoma immunotherapy researcher at The Angeles Clinic and Cedars-Sinai in Los Angeles, an investigator in early trials of ipilimumab and pembrolizumab.
Otto Mühlbock
Otto Mühlbock (1906–1979) was a Dutch cancer researcher and endocrinologist at the Netherlands Cancer Institute who showed hormones alone can induce mammary cancer in mice and developed the GR mouse strain.
Owen N. Witte
Owen N. Witte is an American cancer biologist at UCLA who showed that BCR-ABL drives leukemia, co-discovered BTK, and laid the groundwork for Gleevec and ibrutinib.
P. Andrew Futreal
P. Andrew Futreal, also known as Andrew Futreal, is a cancer geneticist known for identifying the BRCA1 and BRCA2 genes and BRAF mutations in melanoma.
P. Leif Bergsagel
P. Leif Bergsagel (Peter Leif Bergsagel) is a Canadian-trained hematologist-oncologist at Mayo Clinic in Phoenix, Arizona, who identified recurrent chromosome translocations and NF-κB mutations in multiple myeloma.
Pamela J. Goodwin
Pamela J. Goodwin (Pamela Jean Goodwin) is a Canadian medical oncologist and clinical epidemiologist at Mount Sinai Hospital, Toronto, known for research on breast cancer outcomes.
Paola D Vermeer
Paola D Vermeer is an American cancer biologist who heads the Vermeer Lab at Sanford Research in Sioux Falls, South Dakota, studying how nerves recruited by tumors affect immunity.
Paolo A. Ascierto
Paolo A. Ascierto, also known as Paolo Antonio Ascierto, is an Italian medical oncologist who led melanoma and immunotherapy research at the Istituto Nazionale Tumori in Naples.
Paolo Boffetta
Paolo Boffetta is an Italian cancer epidemiologist who studies how tobacco, alcohol, occupation, and environment affect cancer risk, and teaches at the University of Bologna.
Paolo M. Comoglio
Paolo M. Comoglio, also known as Paolo Maria Comoglio, is an Italian molecular oncologist who identified the MET and RON receptors and introduced the concept of invasive growth.
Paolo Sassone-Corsi
Paolo Sassone-Corsi (1956–2020) was an Italian-born molecular biologist at UC Irvine who showed how the circadian clock is built into chromosomes and metabolism, notably proving the clock protein CLOCK is a chromatin-modifying enzyme.
Paolo Vineis
Paolo Vineis is an Italian physician and cancer epidemiologist who holds the Chair of Environmental Epidemiology at Imperial College London, working in molecular epidemiology and exposomics.
Parkash S. Gill
Parkash S. Gill is an American oncologist and physician-scientist at USC's Keck School of Medicine, known for Kaposi's sarcoma research and developing three FDA-approved cancer drugs.
Pasi A. Jänne
Pasi A. Jänne is an American thoracic medical oncologist at Dana-Farber Cancer Institute in Boston who co-discovered EGFR mutations that make lung tumors respond to targeted drugs.
Patricia A. Ganz
Patricia A. Ganz is an American medical oncologist at UCLA, known as a pioneer in cancer quality-of-life measurement and survivorship care, directing cancer prevention research there since 1993.
Patricia LoRusso
Patricia M. LoRusso is an American medical oncologist who leads early-phase clinical trials of experimental cancer drugs at Yale, after 26 years building phase I trials at Wayne State's Karmanos Cancer Institute.
Patricia S. Steeg
Patricia S. Steeg is an American cancer molecular biologist who discovered nm23, the first metastasis suppressor gene, and spent over forty years at the National Institutes of Health.
Patrick A. Baeuerle
Patrick A. Baeuerle is a German immunologist and cancer-drug developer known for discovering the NF-κB inhibitor IκB and for developing blinatumomab (Blincyto), the first bispecific T-cell engager approved for leukemia, in 2014.
Patrick A. Ott
Patrick A. Ott, also known as Patrick Alexander Ott, is a medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School who develops personalized neoantigen vaccines for melanoma.
Patrick Hwu
Patrick Hwu is a tumor immunologist and the president and CEO of Moffitt Cancer Center in Tampa, Florida, since 2020, after 17 years in leadership at MD Anderson.
Patrick J. Loehrer
Patrick J. Loehrer is an American medical oncologist at the Indiana University School of Medicine whose trials helped define modern cisplatin-based treatment of testicular cancer.
Patrick Johnston (medical oncologist)
Patrick Gerard Johnston, known as Paddy, was a Northern Irish medical oncologist who researched chemotherapy drug resistance in gastrointestinal cancer and led Queen's University Belfast from 2014 until his death in 2017.
Patrick M. Forde
Patrick M. Forde is an Irish medical oncologist who led the 2018 first study of immunotherapy before lung cancer surgery and the CheckMate 816 trial, and chairs immuno-oncology at Trinity College Dublin.
Patrick Mehlen
Patrick Mehlen (born 1968) is a French cancer biologist who directs the Cancer Research Center of Lyon and is known for the dependence receptor paradigm.
Patrick S. Moore
Patrick S. Moore is a physician-scientist at the University of Pittsburgh who, with his wife Yuan Chang, discovered the cancer viruses KSHV and Merkel cell polyomavirus.
Patrick Schöffski
Patrick Schöffski is a German medical oncologist and full professor at KU Leuven who heads medical oncology at University Hospitals Leuven and sarcoma drug trials.
Paul A. Bunn
Paul A. Bunn is an American medical oncologist at the University of Colorado Cancer Center, known for lung cancer research and for leading ASCO and the IASLC.
Paul B. Fisher
Paul B. Fisher is an American cancer biologist at Virginia Commonwealth University whose laboratory cloned IL-24, a cytokine that selectively kills cancer cells while sparing normal tissue.
Paul Brennan (cancer epidemiologist)
Paul Brennan is a cancer genetic epidemiologist who heads the Genetics Section at IARC in Lyon, France, studying genetic and environmental causes of lung, kidney, and head and neck cancers.
Paul C. Boutros
Paul C. Boutros is a Canadian-trained computational cancer biologist known for prostate cancer genomics, who directs the NCI-designated cancer center at Sanford Burnham Prebys in San Diego.